Related Experiment Videos

Bacterial meningitis in infants two to six weeks old

Helvetica Paediatrica Acta
|October 1, 1986
PubMed

Insights

Bacterial meningitis in older neonates (2-6 weeks) presents unique challenges. Early antibiotic selection must cover a broad spectrum of pathogens due to high mortality and neurologic sequelae in this distinct age group.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neonatology

Background:

  • Bacterial meningitis is a serious infection in neonates.
  • Older neonates (2-6 weeks) represent a distinct demographic with potentially different causative agents and outcomes compared to younger infants.

Purpose of the Study:

  • To review the experience with bacterial meningitis in older neonates.
  • To identify common pathogens, treatment outcomes, and associated neurologic sequelae.
  • To inform optimal antibiotic selection for this specific age group.

Main Methods:

  • Retrospective review of 17 patients diagnosed with bacterial meningitis.
  • Analysis of causative bacteria isolated from cerebrospinal fluid (CSF).
  • Evaluation of clinical presentation, treatment, mortality, and neurologic outcomes.

Main Results:

  • Common pathogens included pneumococci (29%), E. coli (23%), meningococci (23%), group B streptococci (12%), Enterobacter (6%), and H. influenzae (6%).
  • No Listeria monocytogenes infections were observed.
  • High mortality rate (30%) and significant neurologic residua (36%) were noted.
  • Mean duration of symptoms before admission was 3.1 days.

Conclusions:

  • Older neonates with bacterial meningitis exhibit a different spectrum of pathogens than younger infants.
  • The high mortality and morbidity underscore the need for prompt and appropriate treatment.
  • Empiric antibiotic therapy should encompass the identified spectrum of potential pathogens in this age group.

Related Concept Videos